微RNAs作为预后生物标志物和治疗点在冠状腺癌
Palina Skipar1,2, Mritunjoy Dey1, Jakub Piątkowski3
1Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Cancer Research Institute in Warsaw, 02-781 Warsaw, Poland.
International journal of molecular sciences
|March 28, 2024
概括
微RNAs (miRNAs) 是软骨肉瘤发展的关键. 研究强调了它们作为这种骨癌的诊断标记物和治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 软骨肉瘤是第二个最常见的原发性恶性骨瘤,呈现出各种不同的临床行为.
- 由于预后变化和转移潜力,管理具有挑战性.
- 微RNA (miRNA) 失调越来越多地被认为是冠状腺癌的病原体.
研究的目的:
- 审查当前关于miRNA在冠状腺癌的研究.
- 探索miRNA在诊断,预后和治疗中的作用.
- 检查miRNA对细胞周期,耐药性和干细胞表型的影响.
主要方法:
- 对近期关于miRNA在冠状动脉瘤中的研究的文献综述.
- 分析不同表达的miRNAs在软骨瘤与正常软骨.
- 在基因调节和细胞过程中研究miRNA功能.
主要成果:
- 在冠状腺癌中发现的差异表达的miRNAs.
- miRNAs显示出作为诊断和预后生物标志物的潜力.
- miRNAs与细胞循环调节,耐药性和干细胞特性有关.
结论:
- miRNA研究为冠状腺癌的诊断和治疗提供了新的途径.
- 向miRNAs可以克服耐药性并调节疾病的进展.
- 了解miRNA的作用可以改善患有冠状骨肉瘤的患者的治疗结果.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K